Skip to content

Acupuncture for Insomnia: a Randomized Controlled Trial

Acupuncture Based on Different Acupoints Combination for Insomnia: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02594670
Acronym
AI-RCT
Enrollment
333
Registered
2015-11-03
Start date
2015-10-31
Completion date
2017-08-31
Last updated
2015-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Initiation and Maintenance Disorders

Keywords

acupoints, insomnia, acupuncture, randomized controlled trial

Brief summary

Selecting different acupoints as an combination of acupoints is a key factor to clinical efficacy of acupuncture. Different combinations of acupoints will generate different clinical efficacy. So,the purpose of this study is to determine the different clinical efficacy among three types of combinations of acupoints in the treatment of primary insomnia.

Interventions

OTHERDU20 and HT7 combination

acupoints combination includes Baihui (DU20) and Shenmen(HT7),which was considered as the optimal clinical efficay among various combinations of acupoints.

OTHERDU20 and SP6 combination

acupoints combination of Baihui (DU20) and Sanyinjiao (SP6), which should have some clinical efficay among various combinations of acupoints.

OTHERDU20 and SA combination

Combination of Baihui (DU20) and a Sham acupoint (SA), which should have least clinical efficacy among these three types of acupoints combinations.

Sponsors

University of British Columbia
CollaboratorOTHER
Ministry of Science and Technology of the People´s Republic of China
CollaboratorOTHER_GOV
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed as insomnia based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,2013, American psychiatric association * PSQI score \>7 * AIS score ≥6 * SDS ≤60 * SAS ≤60 * Age between 18 and 65 years old * Not involved in other clinical trial in the lasted 6 months before screening * Have the ability to write the informed consent.

Exclusion criteria

* Breathing-related sleep disorders * Circadian rhythm sleep-wake disorders * Medication-induced sleep disorder * Substance induced sleep disorders,such as alcohol, coffee, strong tea * Secondary insomnia caused by systemic diseases or caused by external environment disturbance * Pregnant or lactating women * Combined with serious cardiovascular, lung, liver, kidney, hematopoietic system, and mental diseases * Advanced malignant tumor or other serious debilitating diseases * Location of acupoints combined with infection and bleeding * Declined to acupuncture * Couldn't provide the written informed consent.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index (PSQI)4 weeks

Secondary

MeasureTime frame
Athens Insomnia Scale (AIS)4 weeks and 8 weeks
Short Form 36-item Health Survey(SF-36)4 weeks and 8 weeks
Self-anxiety scale (SAS)4 weeks and 8 weeks
Self-depression scale (SDS)4 weeks and 8 weeks

Other

MeasureTime frameDescription
safety evaluation will summarize the incidence of adverse events,including itching and redness of local acupoints.4 weeks
adherence of acupuncture4 weeksadherence to the treatment (adherence rate)will be calculated using formula: Adherence Rate = Number of Treatment Conducted/ Number of Treatment Planned

Countries

China

Contacts

Primary ContactYan Wang
48770045@qq.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026